| Literature DB >> 31689235 |
Shelby L Oke1,2,3,4,5, Gurjeev Sohi4,5, Daniel B Hardy1,2,3,4,5.
Abstract
Epidemiological data suggest an inverse relationship between birth weight and long-term metabolic deficits, which is exacerbated by postnatal catch-up growth. We have previously demonstrated that rat offspring subject to maternal protein restriction (MPR) followed by catch-up growth exhibit impaired hepatic function and ER stress. Given that mitochondrial dysfunction is associated with various metabolic pathologies, we hypothesized that altered expression of p66Shc, a gatekeeper of oxidative stress and mitochondrial function, contributes to the hepatic defects observed in MPR offspring. To test this hypothesis, pregnant Wistar rats were fed a control (20% protein) diet or an isocaloric low protein (8%; LP) diet throughout gestation. Offspring born to control dams received a control diet in postnatal life, while MPR offspring remained on a LP diet (LP1) or received a control diet post weaning (LP2) or at birth (LP3). At four months, LP2 offspring exhibited increased protein abundance of both p66Shc and the cis-trans isomerase PIN1. This was further associated with aberrant markers of oxidative stress (i.e. elevated 4-HNE, SOD1 and SOD2, decreased catalase) and aerobic metabolism (i.e., increased phospho-PDH and LDHa, decreased complex II, citrate synthase and TFAM). We further demonstrated that tunicamycin-induced ER stress in HepG2 cells led to increased p66Shc protein abundance, suggesting that ER stress may underlie the programmed effects observed in vivo. In summary, because these defects are exclusive to adult LP2 offspring, it is possible that a low protein diet during perinatal life, a period of liver plasticity, followed by catch-up growth is detrimental to long-term mitochondrial function.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31689235 PMCID: PMC6933810 DOI: 10.1530/REP-19-0188
Source DB: PubMed Journal: Reproduction ISSN: 1470-1626 Impact factor: 3.906
Figure 1Maternal protein restriction (MPR) and postnatal catch-up growth together increase hepatic p66Shc and PIN1 in 4-month-old male offspring. (A) Percent protein composition and timing of nutritional intervention of each MPR diet. Transcript and protein abundances of p66Shc and Pin1 were determined via quantitative real-time PCR and Western immunoblotting, respectively. Relative transcript abundance of (B) p66Shc and (C) Pin1 were expressed as means normalized to the geometric mean of β-actin and GAPDH ± s.e.m. (n = 7–8/group). (D) Representative western immunoblots for specific targeted protein bands of control, LP1, LP2 and LP3 offspring as detected by primary antibodies for p66Shc and PIN1. Relative protein abundances of (E) p66Shc and (F) PIN1 at 4 months of age were expressed as means normalized to β-Actin ± s.e.m. (n = 7–8/group). All qRT-PCR data were analyzed using a one-way ANOVA and multiple comparisons test, while protein abundances were compared using a two-tailed unpaired Student’s t-test. *Significant difference (P < 0.05).
Forward and reverse sequences for primers used in analysis of mRNA targets via quantitative real-time PCR.
| Gene | Forward sequence | Reverse sequence | GenBank/Reference |
|---|---|---|---|
| CAGCTCAGGCCGTGTCTACTA | TCCGAGATTGGCTGTGCTTC | NM_001106701.2 | |
| TACTTGGTTCGGGTGAGTGC | GAGCAGGAAGTCCCGACAAA | NM_053517.2 | |
| CCGAGAACGCAACTCAGGTA | CCTAAGACACCACCAGCATGT | NM_001006972.1 | |
| β-Actin | CACAGCTGAGAGGGAAAT | TCAGCAATGCCTGGGTAC | NM_031144 |
| GGATACTGAGAGCAAGAGAGAGG | TCCTGTTGTTATGGGGTCTGG | NM_017008.4 |
Western blot primary and secondary antibodies, dilutions and company/catalog information.
| Antibody name | Source | Dilution | Company (catalogue no.) |
|---|---|---|---|
| SHC1 | Mouse monoclonal | 1:1000 | Acris Antibodies, Rockville, MD, USA (AM00143PU-N) |
| Pin1 (G-8) | Mouse monoclonal | 1:1000 | Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA (sc-46660) |
| 4-Hydroxynonenal | Mouse monoclonal | 1:1000 | R&D Systems, Oakville, ON, Canada (MAB3249) |
| Superoxide dismutase (SOD)-1 (FL-154) | Rabbit polyclonal | 1:1000 | Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA (sc-11407) |
| Superoxide dismutase (SOD)-2 (FL-222) | Rabbit polyclonal | 1:1000 | Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA (sc-30080) |
| Catalase (H-300) | Rabbit polyclonal | 1:1000 | Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA (sc-50508) |
| pSer(232) pyruvate dehydrogenase | Rabbit polyclonal | 1:1000 | EMD Millipore, Etobicoke, ON, Canada (AP1063) |
| Pyruvate dehydrogenase | Rabbit polyclonal | 1:1000 | Cell Signaling Technology Inc., Danvers, MA, USA (2784S) |
| LDHa | Rabbit polyclonal | 1:1000 | Cell Signaling Technology Inc., Danvers, MA, USA (2012S) |
| Citrate synthase | Rabbit polyclonal | 1:1000 | Provided by Dr S. Raha, McMaster University |
| OXPHOS rodent cocktail | Mouse monoclonal | 1:1000 | Abcam Inc., Toronto, ON, Canada (ab110413) |
| TFAM (D5C8) | Rabbit monoclonal | 1:1000 | Cell Signaling Technology Inc., Danvers, MA, USA (8076S) |
| KDEL ER marker (10C3) | Mouse monoclonal | 1:250 | Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA (sc-58774) |
| β-Actin peroxidase | Mouse monoclonal | 1:25,000 | Sigma Aldrich Co., St. Louis, MO, USA (A3854-200UL) |
| Goat anti-rabbit IgG HRP-linked (H + L chain) | N/A | 1:10,000 | Cell Signaling Technology Inc., Danvers, MA, USA (7074P2) |
| Horse anti-mouse IgG HRP-linked (H + L chain) | N/A | 1:10,000 | Cell Signaling Technology Inc., Danvers, MA, USA (7076S) |
Maternal protein restriction followed by restoration of dietary protein leads to rapid postnatal catch-up growth by 4 months of age.
| d21 | d130 | |
|---|---|---|
| Body weight (g) | ||
| Control | 48.75 ± 1.06* | 544.25 ± 10.30†‡ |
| LP1 | 26 ± 0.53† | 467 ± 15.82* |
| LP2 | N/A | 504.38 ± 11.35*† |
| LP3 | 46.14 ± 2.97* | 602 ± 22.12‡ |
| Liver weight (g) | ||
| Control | 1.91 ± 0.07* | 17.16 ± 1.84* |
| LP1 | 0.86 ± 0.001† | 15.60 ± 0.84* |
| LP2 | N/A | 16.94 ± 0.79* |
| LP3 | 1.65 ± 0.002* | 19.30 ± 1.54* |
| Liver to body weight ratio | ||
| Control | 0.04 ± 0.001* | 0.031 ± 0.003* |
| LP1 | 0.03 ± 0.001† | 0.033 ± 0.001* |
| LP2 | N/A | 0.033 ± 0.001* |
| LP3 | 0.04 ± 0.001† | 0.032 ± 0.002* |
For offspring at both timepoints, liver growth was assessed by calculating liver to body weight ratio. All data are expressed as means ± s.e.m., and dietary effects were determined using one-way ANOVA followed by Tukey’s multiple comparisons test. Groups labeled with different symbols (*, †, ‡) are significantly different from each other.
Figure 2Maternal protein restriction leads to increased markers of hepatic oxidative stress at 4 months of age. (A) Representative Western immunoblots illustrating expression of 4-hydroxynonenal, a marker of lipid peroxidation, superoxide dismutase (SOD)1 and SOD2 in LP1, LP2 and LP3 offspring relative to control diet-fed offspring. Protein abundances of (B) 4HNE, (C) SOD1, (D) SOD2, and (E) catalase in each group of MPR offspring were each compared against control offspring. 4HNE abundance was expressed as means normalized to total protein abundance ± s.e.m. (n = 7–8/group), while SOD1, SOD2 and catalase abundance was normalized to β-Actin ± s.e.m. (n = 7–8/group). All protein abundances were analyzed using a two-tailed unpaired Student’s t-test. *Significant difference (P < 0.05), **significant difference (P < 0.01), ***significant difference (P < 0.001).
Figure 3Maternal protein restriction and postnatal catch-up growth together lead to aberrant markers of aerobic metabolism at 4 months of age. (A) Representative Western immunoblots for specific targeted protein bands for control, LP1, LP2 and LP3 offspring as detected by primary antibodies. Protein abundances of (B) phosphorylated pyruvate dehydrogenase (PDH) to total PDH, (C) lactate dehydrogenase subunit A (LDHa), (D) citrate synthase, (E) complex II, and (G) mitochondrial transcription factor A (TFAM) in LP1, LP2 and LP3 offspring were compared against control diet-fed offspring and expressed as means normalized to β-Actin ± s.e.m. (n = 7–8/group). (F) Transcript abundance of NADH:ubiquinone oxidoreductase core subunit V1 (ND1), a marker of mitochondrial number, was expressed as means normalized to geometric means of β-Actin and GAPDH ± s.e.m. (n = 7–8/group). All qRT-PCR data were analyzed using a one-way ANOVA and multiple comparisons test, while protein abundances were compared using a two-tailed unpaired Student’s t-test. *Significant difference (P < 0.05), **significant difference (P < 0.001), ****significant difference (P < 0.0001).
Figure 4Maternal protein restriction does not independently contribute to increased p66Shc or oxidative stress at 3 weeks of age. (A) Representative Western immunoblots of specific targeted protein bands for control, LP1/LP2, and LP3 offspring as detected by primary antibodies. (B) p66Shc, (C) PIN1, (D) 4HNE, (E) p-PDH, (F) citrate synthase, and (G) complex II protein abundances were compared in each group of MPR offspring against control offspring. 4HNE abundance was expressed as means normalized to total protein abundance ± s.e.m. (n = 7–8/group), while abundances of all other targets were normalized to β-Actin ± s.e.m. (n = 7–8/group). All protein abundances were analyzed using a two-tailed unpaired Student’s t-test. *Significant difference (P < 0.05), **significant difference (P < 0.01).
Figure 5Induction of ER stress with tunicamycin results in increased protein abundance of p66Shc in the HepG2 cell line. (A) Representative Western blots illustrating protein abundance of GRP94 and p66Shc in HepG2 cells treated with either DMSO vehicular control for 1 h (V1), 2 h (V2) or 6 h (V6), or 0.5 µg/mL tunicamycin for 1 h (T1), 2 h (T2) or 6 h (T6). Fold change difference of (B) p66Shc and (C) GRP94 were expressed as means from three biological replicates normalized to β-Actin ± s.e.m., and again normalized to untreated control cells at 0 h (V0). Protein abundances for each time point were analyzed using a two-tailed unpaired Student’s t-test. *Significant difference (P < 0.05).
Figure 6Proposed schematic illustrating the effects of perinatal protein restriction in combination with postnatal catch-up growth on hepatic mitochondrial health. In summary, LP2 offspring were the only experimental group subject to MPR that exhibited increased protein abundance of p66Shc and PIN1. These offspring also displayed aberrant markers of oxidative stress and metabolism, indicating that mitochondrial health had become impaired in adulthood following catch-up growth in early life.